Floatz logo

Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Methotrexate
Hodgkins Lymphoma
Therapeutic Advances in Childhood Leukemia ConsortiumP3B (63)
Midostaurin
Acute Myeloid Leukemia
Richard Stone, MDP3B (63)
Mirvetuximab Soravtansine
Primary Peritoneal Carcinoma
AbbVieP3B (63)
MT-5199
Huntington Disease
Neurocrine BiosciencesP3B (63)
Muamycin
Transitional Cell Carcinoma
UroGen Pharma Ltd.P3B (63)
Muamycin
Renal Pelvis Urothelial Carcinoma
UroGen Pharma Ltd.P3B (63)
Multiple Vitamins Injection
Basal Cell Carcinoma
Women's College HospitalP3B (63)
Multiple Vitamins Injection
Squamous Cell Carcinoma
Women's College HospitalP3B (63)
Neurotop
Tuberous Sclerosis
GRIN Therapeutics, Inc.P3B (63)
Niraparib
BRCA1-Related Cancer Predisposition
Qian QinP3B (63)
Nivestim
Cutaneous Melanoma
Vastra Gotaland RegionP3B (63)
Nivestim
Adult T-Cell Leukemia/Lymphoma
Thomas Jefferson UniversityP3B (63)
Nrtx-1001
Temporal Lobe Epilepsy
Neurona TherapeuticsP3B (63)
Olaparib
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P3B (63)
Olaparib
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P3B (63)
Olaparib
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P3B (63)
Olaparib
Primary Peritoneal Serous Adenocarcinoma
NRG OncologyP3B (63)
Olaparib
Primary Peritoneal Carcinoma
University of Colorado, DenverP3B (63)
Orca-T
Acute Lymphoblastic Leukemia
Stanford UniversityP3B (63)
Palbociclib
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP3B (63)
Pegfilgrastim
Diffuse Large B-Cell Lymphoma
Medical College of WisconsinP3B (63)
Pimavanserin
Major Depressive Disorder
Icahn School of Medicine at Mount SinaiP3B (63)
Posiphen
Parkinson Disease
Annovis Bio Inc.P3B (63)
Pralsetinib, Trans-
Neoplasm
Seoul National University Bundang HospitalP3B (63)
Pregabalin
Osteoarthritis
The Catholic University of KoreaP3B (63)
Showing 2376 to 2400 of 5,098 assets
PreviousPage 96 of 204Next